NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...
The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin. She was speaking just ...
14d
Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...
Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...
Kamala Harris and Donald Trump are both pledging to make health care more affordable in the U.S., but have largely different ...
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...
“I’ll lower the cost of insulin and ... from the middlemen who operate between Big Pharma and the insurance companies who use opaque practices to raise your drug prices and profit off your ...
The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin ... three PBMs are the ...
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback